Contineum Therapeutics Prices $90 Million Upsized Public Equity Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Gunderson Dettmer has advised Contineum Therapeutics. Contineum Therapeutics, Inc. (Nasdaq: CTNM) (Contineum) a clinical-stage biopharmaceutical company, has announced the pricing of an upsized underwritten public offering…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here